Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BEVA Congress to consider ‘One Medicine’
'One Medicine' is an adaptation of the widely recognised concept of One Health.
The concept suggests similarities between equine and human illnesses.

This year’s British Equine Veterinary Association (BEVA) Congress is to consider the concept of One Medicine between equine and human care.

One Medicine is an adaptation of the widely recognised concept of One Health, which suggests a unified approach in the health of humans, animals and the ecosystem.

The concept of One Health suggests that, through the collaboration of professionals across different sectors and disciplines, shared knowledge can tackle major issues affecting humans, domesticated animals and wildlife. This includes infectious diseases, antimicrobial resistance and food safety.

This has now been adapted to become ‘One Medicine’ to acknowledge other non-infectious diseases which share similarities across both animals and humans.

Although not all diseases are the same in both horses and humans, there are some treatments produced for either species that can be useful for both.

BEVA president Roger Smith said: “There is much to learn from similar diseases in the two species.

“Treatments developed in either species can be appropriate for both, and the horse can be an ideal ‘proving ground’ for new treatments destined for human medicine.”

Mr Smith has highlighted the Peter Rossdale Clinical Evidence Lecture as one of particular relevance to One Medicine. He says that Dr Rossdale was a keen advocate of medical-veterinary collaborations and evidence-based medicine.

The speaker of this year’s lecture is Andrew Carr, a professor from the University of Oxford and a former director of the Botnar and Kennedy Research Institutes.

Prof Carr is a shoulder surgeon and has developed the basic science around tendon disease. He has also performed controlled studies of surgical techniques for the human shoulder.

Not every talk at the congress will address One Medicine, however speakers have been asked to include examples if possible.

There will be a combined session on the Saturday morning which will explore tendon and ligament disease. Ian Wright, Andy Fiske-Jackson and Andre Buthe will lead on the veterinary side, while orthopaedic surgeon Andrew Goldberg will present the human side.

Mr Goldberg often treats Achilles tendinopathy, which is the human equivalent of superficial digital flexor tendinopathy in horses.

There will also be a talk from author and orthopaedic surgeon Bill Ribbans. Prof Ribbans will explain his view on detecting stress fractures in human athletes and evaluate the case for the social license of equine competition.

Mr Smith said: “We hope that the theme of ‘One Medicine’ will not only be interesting to delegates but also potentially provide some ideas for new diagnostic and/or management strategies for the cases we see as clinicians.”

BEVA Congress will take place from 11-14 September 2024 at the ACC in Liverpool. The full BEVA programme can be found here.

Image © BEVA

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.